GNA11 mutations were analyzed in all types of thyroid cancer (PTC, FTC and ATC) as they have been frequently identified in uveal melanoma and are known to activate the MAPK signaling pathway (5), which is one of the most deregulated signaling pathways in thyroid cancer (3). This evidence concerns the gene GNA11 and thyroid gland carcinoma.